Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 11-2011 | 09-2011 | 08-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,260 | -11 | N/A | -7 | N/A |
| Accounts payable and accrued liabilities | 340 | 2 | N/A | 1 | N/A |
| Other Working Capital | 500 | 2 | 1 | 1 | 1 |
| Other Operating Activity | 1,640 | 8 | 6 | 5 | 3 |
| Operating Cash Flow | $-780 | $0 | $7 | $0 | $4 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | 0 | N/A | 0 |
| Purchase Of Investment | -10 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 3 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-10 | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 763 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 37 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $800 | $N/A | $0 | $N/A | $0 |
| Beginning Cash Position | 0 | 4 | N/A | 4 | N/A |
| End Cash Position | 10 | 4 | N/A | 4 | N/A |
| Net Cash Flow | $10 | $0 | $7 | $0 | $4 |
| Free Cash Flow | |||||
| Operating Cash Flow | -780 | 0 | 7 | 0 | 4 |
| Capital Expenditure | -3 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -783 | 0 | 7 | 0 | 4 |